Table 2.
Furosemide (n = 30) | Tolvaptan (n = 30) | P‐value | |
---|---|---|---|
Furosemide | 13 (43%) | 14 (47%) | 0.79 |
Dose, mg/day | 20 (20–40) | 40 (20–40) | 0.61 |
Aldosterone antagonist | 7 (23%) | 9 (30%) | 0.56 |
Thiazide | 1 (3%) | 2 (7%) | 0.55 |
Digoxin | 3 (10%) | 4 (13%) | 0.69 |
β blocker | 12 (40%) | 12 (40%) | 1.00 |
ACE inhibitor | 2 (7%) | 4 (13%) | 0.39 |
ARB | 10 (33%) | 9 (30%) | 0.78 |
Calcium channel blocker | 13 (43%) | 10 (33%) | 0.43 |
ISDN | 4 (13%) | 4 (13%) | 1.00 |
Statin | 10 (33%) | 5 (17%) | 0.14 |
ACE: angiotensin converting enzyme; ARB: angiotensin II receptor blocker; ISDN: isosorbide dinitrate.
Data presented as number (%), or median with interquartile range.